-
Add to Cart The item has been added127670-1GAdenosine 5-monophosphate monohydrate 1g
Price: $86.99List Price: $96.66CAS: 61-19-8 EC No: 200-500-0 MDL No: MFCD00149360 RTECS: AU7480500 Crystalline/Powder Molecular Formula: C<sub>10</sub>H<sub>14</sub>N<sub>5</sub>O<sub>7</sub>P·H<sub>2</sub>O MW: 365.24 -
Add to Cart The item has been added119135-25MGADENOSINE A1 RECEPTOR AGONIS 1 PC X 25 M
Price: $217.55List Price: $241.72A potent and selective agonist of adenosine A1 receptor (A1R) (K i = 2.3 nM, 790 nM, 18. -
Add to Cart The item has been added119149-5MGADENOSINE A2A RECEPTOR ANTAG 1PC X 5MG
Price: $319.17List Price: $354.63A highly potent, selective, and orally bioavailable non-xanthine adenosine A 2A receptor antagonist (K i = 800 pM for human adenosine A 2A R stably expressed in HEK-293 cells). Does not exhibit any significant antagonistic activity in A 1 , A 2B (K -
Add to Cart The item has been addedC2948-5 mgAdenosine analog and adenosine receptor agonist that terminates DNA chain elongation. It induces double-stranded DNA breaks and apoptosis in lung cancer cells. It also stimulates arterial dilation and decreases expression of TNF-a. (C003B-254865)
Price: $144.11List Price: $160.12Chloroadenosine is a nucleoside analog that exhibits anticancer, vasodilatory, and anti-inflammatory activities. Chloradenosine induces double-stranded DNA breaks and apoptosis in lung cancer cells. -
Add to Cart The item has been addedC2948-10 mgAdenosine analog and adenosine receptor agonist that terminates DNA chain elongation. It induces double-stranded DNA breaks and apoptosis in lung cancer cells. It also stimulates arterial dilation and decreases expression of TNF-a. (C003B-254931)
Price: $187.34List Price: $208.15Chloroadenosine is a nucleoside analog that exhibits anticancer, vasodilatory, and anti-inflammatory activities. Chloradenosine induces double-stranded DNA breaks and apoptosis in lung cancer cells. -
Add to Cart The item has been addedC2948-50 mgAdenosine analog and adenosine receptor agonist that terminates DNA chain elongation. It induces double-stranded DNA breaks and apoptosis in lung cancer cells. It also stimulates arterial dilation and decreases expression of TNF-a. (C003B-255052)
Price: $215.92List Price: $239.91Chloroadenosine is a nucleoside analog that exhibits anticancer, vasodilatory, and anti-inflammatory activities. Chloradenosine induces double-stranded DNA breaks and apoptosis in lung cancer cells. -
Add to Cart The item has been added116860-10MGADENOSINE DEAMINASE INHIBITO 1PC X 10MG
Price: $351.97List Price: $391.07A cell-permeable purine nucleoside compound that acts as a highly potent, tight binding transition state analog inhibitor of adenosine deaminase (ADA K i = 2.5 pM against partially purified human erythrocytes, and 0. -
Add to Cart The item has been addedA5043-1KUADENOSINE DEAMINASE TYPE X FROM CALF SPLEEN (C005B-089028)
Price: $2,985.01List Price: $3,316.68Molecular weight: 32.5-33 kDa pI: 4. -
Add to Cart The item has been addedA5043-250UNADENOSINE DEAMINASE TYPE X FROM CALF SPLEEN (C005B-089029)
Price: $959.88List Price: $1,066.53Molecular weight: 32.5-33 kDa pI: 4. -
Add to Cart The item has been addedMAK433-1KTADENOSINE QUANTIFICATION ASSAY KIT
Price: $1,508.11List Price: $1,675.68General description Adenosine is a purine nucleoside base, which is the precursor of adenosine triphosphate, or ATP, and is utilized thoroughly throughout the entire body in general metabolism. Extracellular adenosine acts as a local modulator -
Add to Cart The item has been addedA650613-10mgAdenosine receptor antagonist 3 (C007B-325869)
Price: $582.80List Price: $647.56Adenosine receptor antagonist 3 is a potent antagonist of adenosine receptor. Adenosine receptor antagonist 3 has the potential for the research of cancer disease (extracted from patent WO2019233994A1, compound 1).Form:Solid. -
Add to Cart The item has been addedA650613-25mgAdenosine receptor antagonist 3 (C007B-325870)
Price: $1,156.50List Price: $1,285.00Adenosine receptor antagonist 3 is a potent antagonist of adenosine receptor. Adenosine receptor antagonist 3 has the potential for the research of cancer disease (extracted from patent WO2019233994A1, compound 1).Form:Solid.
